Research has shown that adaptive immunity components CD4+ T cells, CD8+ T cells, IL12, and IFNγ are in charge of keeping tumor cells in balance by exerting immune selection pressure (Figure 3) (1, 2). This evidence concerns the gene CD8A and neoplasm.